2004
DOI: 10.1007/s00213-003-1639-z
|View full text |Cite
|
Sign up to set email alerts
|

Differential region-specific regulation of central ?1-adrenoceptor binding following chronic haloperidol and clozapine administration in the rat

Abstract: Central alpha(1)-adrenoceptors are differentially regulated after chronic haloperidol and clozapine treatment. It is suggested that thalamic alpha(1)-adrenoceptors may represent a common anatomical locus contributing to the antipsychotic activity and/or alpha(1)-adrenoceptor centrally mediated side effects of both drugs, whereas the selective upregulation of cortical alpha(1)-adrenoceptor density by clozapine may contribute, in part, to its superior atypical properties.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 37 publications
0
9
0
Order By: Relevance
“…Many sources cite the antagonism of the α 1A -AR subtype as mediating this antipsychotic action though the data may not support this claim sufficiently, as the conclusions were based on studies performed in the peripheral nervous system while studying side effects (183) or not actually focused on the α 1 -AR subtypes (184). The binding affinities of clozapine for α 1A - and α 1B -ARs are not significantly different (185,186); however, the observed α 1 -AR up-regulation that occurs with clozapine treatment is mainly in areas of high α 1B -AR expression (187). In addition, the atypical antipsychotic risperidone has 120-fold antagonist selectivity for the α 1B -AR in the hippocampus (185).…”
Section: Neurophysiologymentioning
confidence: 99%
“…Many sources cite the antagonism of the α 1A -AR subtype as mediating this antipsychotic action though the data may not support this claim sufficiently, as the conclusions were based on studies performed in the peripheral nervous system while studying side effects (183) or not actually focused on the α 1 -AR subtypes (184). The binding affinities of clozapine for α 1A - and α 1B -ARs are not significantly different (185,186); however, the observed α 1 -AR up-regulation that occurs with clozapine treatment is mainly in areas of high α 1B -AR expression (187). In addition, the atypical antipsychotic risperidone has 120-fold antagonist selectivity for the α 1B -AR in the hippocampus (185).…”
Section: Neurophysiologymentioning
confidence: 99%
“…Tolerance to the rate-suppressing effect of clozapine in BALB/cJ mice might be a reflection of the upregulation of a 1 noradrenergic receptors, as these proteins have been observed to be upregulated in the rat brain in response to 21-day treatment with clozapine (Cahir et al, 2004). An increase in a 1 receptor density would be consistent with a diminishing effect of clozapine as dosing continued, because clozapine has pronounced a 1 antagonist effects (Schotte et al, 1996).…”
Section: Discussionmentioning
confidence: 86%
“…A previous study reported increases in frontal cortex 3 wk after clozapine administration (Cahir et al 2004). As such, it could be speculated that newer antipsychotics with the ability to block a 1 receptors would also increase cortical a 1 -receptor binding.…”
Section: Discussionmentioning
confidence: 95%